Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.

Chung CJ, Huang CY, Pu YS, Shiue HS, Su CT, Hsueh YM.

Toxicol Appl Pharmacol. 2013 Jan 15;266(2):254-9. doi: 10.1016/j.taap.2012.11.005. Epub 2012 Nov 15.

PMID:
23159782
2.

Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.

Chung CJ, Huang CJ, Pu YS, Su CT, Huang YK, Chen YT, Hsueh YM.

Toxicol Appl Pharmacol. 2008 Oct 15;232(2):203-9. doi: 10.1016/j.taap.2008.06.011. Epub 2008 Jul 1.

PMID:
18640142
3.

Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.

Chung CJ, Pu YS, Su CT, Huang CY, Hsueh YM.

Sci Total Environ. 2011 Jan 1;409(3):465-70. doi: 10.1016/j.scitotenv.2010.10.053. Epub 2010 Nov 21.

PMID:
21094982
4.

Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan.

Hsu LI, Chen WP, Yang TY, Chen YH, Lo WC, Wang YH, Liao YT, Hsueh YM, Chiou HY, Wu MM, Chen CJ.

J Biomed Sci. 2011 Jul 29;18:51. doi: 10.1186/1423-0127-18-51.

5.

Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.

Pu YS, Yang SM, Huang YK, Chung CJ, Huang SK, Chiu AW, Yang MH, Chen CJ, Hsueh YM.

Toxicol Appl Pharmacol. 2007 Jan 15;218(2):99-106. Epub 2006 Nov 10.

PMID:
17196235
6.

A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.

Wang YH, Yeh SD, Shen KH, Shen CH, Juang GD, Hsu LI, Chiou HY, Chen CJ.

Toxicol Appl Pharmacol. 2009 Nov 15;241(1):111-8. doi: 10.1016/j.taap.2009.08.008. Epub 2009 Aug 15.

PMID:
19686770
7.

SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.

Hsu LI, Chiu AW, Huan SK, Chen CL, Wang YH, Hsieh FI, Chou WL, Wang LH, Chen CJ.

Toxicol Appl Pharmacol. 2008 Apr 15;228(2):144-55. doi: 10.1016/j.taap.2007.12.003. Epub 2007 Dec 14.

PMID:
18199464
8.

Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.

Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, Hsu LI, Chen CJ.

Cancer Causes Control. 2008 Oct;19(8):829-39. doi: 10.1007/s10552-008-9146-5. Epub 2008 Mar 20.

PMID:
18351295
9.

XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.

Chiang CI, Huang YL, Chen WJ, Shiue HS, Huang CY, Pu YS, Lin YC, Hsueh YM.

Toxicol Appl Pharmacol. 2014 Sep 15;279(3):373-9. doi: 10.1016/j.taap.2014.06.027. Epub 2014 Jul 10.

PMID:
25018058
10.

Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan.

Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, Wei ML, Chen HC, Yang HT, Leu LC, Chu TH, Chen-Wu C, Yang MH, Chen CJ.

Mutat Res. 1997 Jun;386(3):197-207.

PMID:
9219558
11.

Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.

Wang YH, Yeh SD, Wu MM, Liu CT, Shen CH, Shen KH, Pu YS, Hsu LI, Chiou HY, Chen CJ.

J Hazard Mater. 2013 Nov 15;262:1139-46. doi: 10.1016/j.jhazmat.2012.08.056. Epub 2012 Sep 7.

PMID:
23009795
12.

Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.

Chung CJ, Pu YS, Chen YT, Su CT, Wu CC, Shiue HS, Huang CY, Hsueh YM.

Sci Total Environ. 2011 Feb 15;409(6):1039-45. doi: 10.1016/j.scitotenv.2010.11.037. Epub 2011 Jan 12.

PMID:
21227482
13.

Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.

Wu CC, Huang YK, Chung CJ, Huang CY, Pu YS, Shiue HS, Lai LA, Lin YC, Su CT, Hsueh YM.

Toxicol Appl Pharmacol. 2013 Oct 1;272(1):30-6. doi: 10.1016/j.taap.2013.05.019. Epub 2013 May 31.

PMID:
23727622
15.

[Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].

Chen K, Jiang QT, Ma XY, Yao KY, Leng SG, Yu WP, Zhou HG.

Zhonghua Zhong Liu Za Zhi. 2004 Nov;26(11):645-8. Chinese.

PMID:
15777499
16.

Genetic polymorphism of sulfotransferase 1A1, cigarette smoking, hazardous chemical exposure and urothelial cancer risk in a Taiwanese population.

Wang YH, Juang GD, Hwang TI, Shen CH, Shao KY, Chiou HY.

Int J Urol. 2008 Dec;15(12):1029-34. doi: 10.1111/j.1442-2042.2008.02166.x.

17.

Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.

Huang SK, Chiu AW, Pu YS, Huang YK, Chung CJ, Tsai HJ, Yang MH, Chen CJ, Hsueh YM.

Urol Int. 2009;82(2):227-34. doi: 10.1159/000200805. Epub 2009 Mar 19.

PMID:
19322015
18.

Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.

Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E.

Neoplasma. 1998;45(5):312-7.

PMID:
9921921
19.

Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.

Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D.

Mutat Res. 2008 Feb 1;638(1-2):184-94. Epub 2007 Oct 16.

PMID:
18035380
20.

Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.

London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR.

J Natl Cancer Inst. 1995 Aug 16;87(16):1246-53.

PMID:
7563171

Supplemental Content

Support Center